Nass Valley Gateway has announced that it has terminated the agreements with the 2017 proposed acquisition targets as the requested financial statements, audited by a firm qualified by the CSE to verify the value of the to be acquired assets, were not supplied.  

On March 22, 2018, the Issuer announced the execution of a binding Acquisition and Share Exchange Agreement with Advanced Bioceuticals Limited, a privately-owned company (“ABL”) incorporated under the Laws of New Jersey. Under the terms of the agreement ABL and its wholly owned subsidiary Pro-Thotics Technology Inc. (“PTI”), a New York private corporation with a more than 25 year established business, will become wholly owned subsidiaries of Nass Valley as the “Resulting Issuer”.  

The trading of Nass Valley Gateway's stock will be halted until the company receives final approval from the CSE for its proposed acquisition.